activins has been researched along with Adenoma, Prolactin-Secreting, Pituitary in 4 studies
Activins: Activins are produced in the pituitary, gonads, and other tissues. By acting locally, they stimulate pituitary FSH secretion and have diverse effects on cell differentiation and embryonic development. Activins are glycoproteins that are hetero- or homodimers of INHIBIN-BETA SUBUNITS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Among pituitary adenomas, prolactinomas are the most frequently diagnosed (about 50%)." | 1.72 | Oophorectomy improves pituitary activin inhibitory function preventing lactotroph hyperplasia development. ( Abeledo-Machado, A; Camilletti, MA; Diaz-Torga, G; Faraoni, EY; Gutierrez, S; Marcial López, CA; Peña-Zanoni, M; Perez, PA; Rulli, SB, 2022) |
| "As activins inhibit prolactin gene expression through the inhibition of Pit-1 involving the p38MAPK pathway, in the present work, we studied the local activin system as an alternative inhibitory system for lactotroph hyperplasia treatment." | 1.56 | Activin-inhibitory action on lactotrophs is decreased in lactotroph hyperplasia. ( Abeledo Machado, AI; Camilletti, MA; Díaz-Torga, G; Faraoni, EY; Gutiérrez, S; Marcial López, CA; Peña-Zanoni, M; Pérez, PA; Rulli, SB, 2020) |
| "Discovering markers to identify prolactinoma proliferative and invading character is therefore crucial to develop new diagnostic/prognostic strategies." | 1.48 | ALK7 expression in prolactinoma is associated with reduced prolactin and increased proliferation. ( Auger, C; Bertolino, P; Chanal, M; Gadet, R; Hennino, A; Jouanneau, E; Karam, V; Mikaélian, I; Principe, M; Raverot, G; Raverot, V; Vasiljevic, A; Wierinckx, A, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 2 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Peña-Zanoni, M | 2 |
| Faraoni, EY | 2 |
| Abeledo-Machado, A | 1 |
| Perez, PA | 2 |
| Marcial López, CA | 2 |
| Camilletti, MA | 2 |
| Gutierrez, S | 2 |
| Rulli, SB | 2 |
| Diaz-Torga, G | 2 |
| Abeledo Machado, AI | 1 |
| Principe, M | 1 |
| Chanal, M | 1 |
| Karam, V | 1 |
| Wierinckx, A | 1 |
| Mikaélian, I | 1 |
| Gadet, R | 1 |
| Auger, C | 1 |
| Raverot, V | 1 |
| Jouanneau, E | 1 |
| Vasiljevic, A | 1 |
| Hennino, A | 1 |
| Raverot, G | 1 |
| Bertolino, P | 1 |
| Demura, R | 1 |
| Kubo, O | 1 |
| Suzuki, T | 1 |
| Yajima, R | 1 |
| Tajima, S | 1 |
| Takakura, K | 1 |
| Demura, H | 1 |
| Aiba, M | 1 |
| Eto, Y | 1 |
4 other studies available for activins and Adenoma, Prolactin-Secreting, Pituitary
| Article | Year |
|---|---|
Oophorectomy improves pituitary activin inhibitory function preventing lactotroph hyperplasia development.
Topics: Activins; Adult; Animals; Female; Humans; Hyperplasia; Inhibins; Lactotrophs; Mice; Ovariectomy; Pit | 2022 |
Activin-inhibitory action on lactotrophs is decreased in lactotroph hyperplasia.
Topics: Activins; Animals; Dopamine Agonists; Drug Resistance, Neoplasm; Female; Genotype; Lactotrophs; Male | 2020 |
ALK7 expression in prolactinoma is associated with reduced prolactin and increased proliferation.
Topics: Activin Receptors, Type I; Activins; Animals; Humans; Pituitary Neoplasms; Prolactin; Prolactinoma; | 2018 |
Demonstration of activin in normal pituitary and in various human pituitary adenomas by immunohistochemistry.
Topics: Activins; Adenoma; Cushing Syndrome; Human Growth Hormone; Humans; Immunohistochemistry; Inhibins; P | 1996 |